Page last updated: 2024-10-15

phenylamil

Description

phenylamil: irreversible inhibitor of sodium channels in the toad urinary bladder [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135403792
CHEMBL ID211502
CHEBI ID34919
SCHEMBL ID14504131
SCHEMBL ID4245294
MeSH IDM0136159

Synonyms (59)

Synonym
CBIOL_001870
MLS002172443 ,
BRD-K21350491-001-02-1
BIO2_000153
BIO1_000156
BIO1_001134
BIO2_000633
BIO1_000645
BSPBIO_001433
LOPAC0_000998
IDI1_033903
2038-35-9
phenamil
phenylamil
smr000326941
NCGC00162311-02
NCGC00162311-03
KBIO3_000306
KBIO2_000153
KBIO3_000305
KBIOSS_000153
KBIOGR_000153
KBIO2_002721
KBIO2_005289
NCGC00162311-04
NCGC00162311-05
NCGC00162311-01
HMS1989H15
HMS2089E19
NCGC00162311-06
chebi:34919 ,
CHEMBL211502 ,
HMS1791H15
ST50826156 ,
AC1L1IVQ ,
CCG-205078
pyrazinecarboxamide, 3,5-diamino-6-chloro-n-(imino(phenylamino)methyl)-
3,5-diamino-6-chloro-n-(n-phenylcarbamimidoyl)pyrazine-2-carboxamide
3,5-diamino-n-[(1e)-amino(phenylamino)methylidene]-6-chloropyrazine-2-carboxamide
gtpl4281
SCHEMBL14504131
SCHEMBL4245294
bdbm115076
3,5-bis(azanyl)-n-[azanyl(phenylazanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide;methanesulfonic acid
3,5-diamino-n-[amino(anilino)methylidene]-6-chloropyrazine-2-carboxamide;methanesulfonic acid
cid_9604979
3,5-diamino-n-[amino(anilino)methylene]-6-chloro-pyrazinamide;mesylic acid
3,5-diamino-n-[amino(anilino)methylidene]-6-chloro-2-pyrazinecarboxamide;methanesulfonic acid
3,5-diamino-n-[amino(anilino)methylene]-6-chloro-pyrazine-2-carboxamide
HMS3402H15
DTXSID50942542
Q27088359
SDCCGSBI-0050971.P002
(nz)-3,5-diamino-n-[amino(anilino)methylidene]-6-chloropyrazine-2-carboxamide
NCGC00162311-11
cid 5353878
pyrazinecarboxamide, 3,5-diamino-6-chloro-n-(phenylamidino)-
1,4-dioxane-2-carboxylic?acid
2-pyrazinecarboxamide, 3,5-diamino-6-chloro-n-[imino(phenylamino)methyl]-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
pyrazines
guanidinesAny organonitrogen compound containing a carbamimidamido (guanidino) group. Guanidines have the general structure (R(1)R(2)N)(R(3)R(4)N)C=N-R(5) and are related structurally to amidines and ureas.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thioredoxin reductaseRattus norvegicus (Norway rat)Potency17.89560.100020.879379.4328AID488772; AID588453; AID588456
ATAD5 protein, partialHomo sapiens (human)Potency14.79900.004110.890331.5287AID493106; AID493107
TDP1 proteinHomo sapiens (human)Potency22.55510.000811.382244.6684AID686978; AID686979
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency21.45090.011212.4002100.0000AID1030
67.9K proteinVaccinia virusPotency25.11890.00018.4406100.0000AID720580
ParkinHomo sapiens (human)Potency12.27980.819914.830644.6684AID720572; AID720573
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency22.38720.035520.977089.1251AID504332
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency26.12160.016525.307841.3999AID602332
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency2.05960.01262.451825.0177AID485313
D(1A) dopamine receptorHomo sapiens (human)Potency7.11260.02245.944922.3872AID488982; AID488983
ras-related protein Rab-9AHomo sapiens (human)Potency2.05960.00022.621531.4954AID485297
survival motor neuron protein isoform dHomo sapiens (human)Potency14.98710.125912.234435.4813AID1458
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency8.49210.060110.745337.9330AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Amiloride-sensitive sodium channel subunit alphaHomo sapiens (human)IC50 (µMol)0.40100.06600.41430.7760AID268105
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
intracellular sodium ion homeostasisAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
regulation of blood pressureAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
sodium ion transmembrane transportAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
multicellular organismal-level water homeostasisAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
sensory perception of salty tasteAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
sensory perception of sour tasteAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
sodium ion homeostasisAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
cellular response to acidic pHAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
sodium ion import across plasma membraneAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
cellular response to aldosteroneAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
cellular response to vasopressinAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
ligand-gated sodium channel activityAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
protein bindingAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
WW domain bindingAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
acrosomal vesicleAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
cytoplasmAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
cytosolAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
plasma membraneAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
external side of plasma membraneAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
apical plasma membraneAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
motile ciliumAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
sodium channel complexAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
ciliary membraneAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
extracellular exosomeAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
sperm principal pieceAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
plasma membraneAmiloride-sensitive sodium channel subunit alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508627Counterscreen qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: GLuc-NoTag assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508628Confirmatory qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508629Cell Viability qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID406411Protection against Bacillus anthracis lethal toxin-mediated cytotoxicity in mouse RAW264.7 cells assessed as change in viability at 0.125 to 12.5 uM relative to toxin-treated control2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
Amiodarone and bepridil inhibit anthrax toxin entry into host cells.
AID268105Inhibition of dog bronchi prototypical epithelial sodium channel by electrophysiological assay2006Journal of medicinal chemistry, Jul-13, Volume: 49, Issue:14
Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis.
AID268106Recovery of short-circuit current in dog primary bronchial epithelial cells2006Journal of medicinal chemistry, Jul-13, Volume: 49, Issue:14
Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (103)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (13.59)18.7374
1990's30 (29.13)18.2507
2000's19 (18.45)29.6817
2010's30 (29.13)24.3611
2020's10 (9.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other104 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]